Bio-Rad Laboratories (BIO) Retained Earnings (2016 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Retained Earnings for 17 consecutive years, with $8.2 billion as the latest value for Q4 2025.
- On a quarterly basis, Retained Earnings rose 1619.19% to $8.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.2 billion, a 1619.19% increase, with the full-year FY2025 number at $8.2 billion, up 1619.19% from a year prior.
- Retained Earnings was $8.2 billion for Q4 2025 at Bio-Rad Laboratories, up from $7.5 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $9.6 billion in Q1 2024 to a low of -$845.2 million in Q3 2022.
- A 5-year average of $2.3 billion and a median of -$116.8 million in 2021 define the central range for Retained Earnings.
- Peak YoY movement for Retained Earnings: crashed 22950.0% in 2023, then soared 2465.02% in 2025.
- Bio-Rad Laboratories' Retained Earnings stood at -$170.5 million in 2021, then crashed by 173.61% to -$466.5 million in 2022, then surged by 2085.12% to $9.3 billion in 2023, then plummeted by 105.81% to -$538.2 million in 2024, then soared by 1619.19% to $8.2 billion in 2025.
- Per Business Quant, the three most recent readings for BIO's Retained Earnings are $8.2 billion (Q4 2025), $7.5 billion (Q3 2025), and $7.8 billion (Q2 2025).